tiprankstipranks
Advertisement
Advertisement

Ab&B Bio-Tech Delays 2025 Results, Triggers Trading Suspension in Hong Kong

Story Highlights
  • Ab&B Bio-Tech delayed its 2025 audited results as auditors probe fund investments and consultancy payments.
  • The company postponed its board meeting and faces a trading suspension until audited 2025 results are released.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ab&B Bio-Tech Delays 2025 Results, Triggers Trading Suspension in Hong Kong

Meet Samuel – Your Personal Investing Prophet

Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) has issued an update.

Ab&B Bio-Tech has disclosed that it will delay publication of its audited annual results for the year ended 31 December 2025, as its auditors and the board’s audit committee have yet to complete audit procedures and internal inquiries related to certain fund investments and consultancy payments. Citing concerns that unaudited figures might misrepresent its financial position, the company has postponed its results board meeting, will not issue interim management accounts, and will face a trading suspension in its shares from 1 April 2026 until the 2025 results are released, signaling heightened uncertainty for shareholders and potential investors.

The delay also means Ab&B Bio-Tech is in non-compliance with Hong Kong’s listing rules on timely financial disclosure, prompting the automatic suspension of trading in its stock by the exchange. The company has said it will announce new dates for the board meeting, the results publication, and any significant developments once the outstanding audit issues are resolved, leaving the market awaiting clarity on both its financial performance and the outcome of the ongoing investigations.

The most recent analyst rating on (HK:2627) stock is a Sell with a HK$47.00 price target. To see the full list of analyst forecasts on Ab&B Bio-Tech CO., LTD. JS Class H stock, see the HK:2627 Stock Forecast page.

More about Ab&B Bio-Tech CO., LTD. JS Class H

Ab&B Bio-Tech Co., Ltd. JS is a biotechnology company incorporated in the People’s Republic of China and listed on the Hong Kong Stock Exchange. The group focuses on bio-tech related operations, though specific products and services are not detailed in the announcement, and it serves investors in the Hong Kong capital market through its H-share listing.

Average Trading Volume: 663,514

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$11.65B

Find detailed analytics on 2627 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1